D
Stoke Therapeutics, Inc. STOK
$19.56 -$0.12-0.61% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 199.89M 190.91M 36.56M 16.74M 15.16M
Total Other Revenue -- -- -- -- --
Total Revenue 199.89M 190.91M 36.56M 16.74M 15.16M
Cost of Revenue -- -- -- -- --
Gross Profit 199.89M 190.91M 36.56M 16.74M 15.16M
SG&A Expenses 55.45M 53.23M 48.79M 46.56M 44.14M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 159.61M 152.67M 137.93M 134.05M 129.69M
Operating Income 40.28M 38.24M -101.37M -117.30M -114.53M
Income Before Tax 53.76M 51.55M -88.98M -105.46M -103.57M
Income Tax Expenses 1.28M 1.28M -- -- --
Earnings from Continuing Operations 52.48 50.27 -88.98 -105.46 -103.57
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 52.48M 50.27M -88.98M -105.46M -103.57M
EBIT 40.28M 38.24M -101.37M -117.30M -114.53M
EBITDA 42.27M 40.33M -99.19M -115.03M -112.16M
EPS Basic 0.90 0.84 -1.68 -2.10 -2.19
Normalized Basic EPS 0.57 0.54 -1.05 -1.31 -1.37
EPS Diluted 0.84 0.79 -1.68 -2.10 -2.19
Normalized Diluted EPS 0.54 0.51 -1.05 -1.31 -1.37
Average Basic Shares Outstanding 229.59M 227.00M 215.38M 203.31M 191.24M
Average Diluted Shares Outstanding 231.12M 228.53M 215.38M 203.31M 191.24M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --